Malin Corporation | MLC - Loan Capital


Malin Corporation reported EUR0 in Loan Capital for its fiscal semester ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
ALKERMES USD 285.82M 639K Sep/2024
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Eurofins Scientific SE EUR 3.7B 129.7M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Lonza CHF 4.24B 602M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 610M 584M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 100K 86K Sep/2025
Viatris USD 12.49B 304M Sep/2025
Xeris Pharmaceuticals USD 219.47M 839K Sep/2025